Financial return-on-investment of ophthalmic interventions: A new paradigm

Current Opinion in Ophthalmology

Volumn 25, Issue 3, 2014, Pages 171-176

  Brown, Melissa M ^a,b,c   Brown, Gary C ^a,b,c   Lieske, Heidi B ^a   Lieske, P Alexander ^a  

^a CENTER FOR VALUE BASED MEDICINE   (United States)

^b WILLS EYE HOSPITAL   (United States)

^c Eye Research Institute   (United States)

Author keywords

financial return on investment; increased national wealth; interventions; ophthalmologic; patient value gain; vitreoretinal

Indexed keywords

RANIBIZUMAB;

CAREGIVER; CATARACT EXTRACTION; COST UTILITY ANALYSIS; DEPRESSION; EMPLOYMENT; EYE CARE; GROSS NATIONAL PRODUCT; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HUMAN; INJURY; INTERVENTION STUDY; INVESTMENT; NURSING; NURSING HOME; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; QUALITY OF LIFE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW;

ANTIBODIES, MONOCLONAL, HUMANIZED; CATARACT EXTRACTION; COST-BENEFIT ANALYSIS; DIRECT SERVICE COSTS; ECONOMICS, MEDICAL; GLAUCOMA, OPEN-ANGLE; HUMANS; MACULAR DEGENERATION; OPHTHALMOLOGY; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS;

EID: 84898449298     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0000000000000040     Document Type: Review

References (20)

1. Brown GC, Brown MM, Kertes P. Value-based medicine cost-utility analysis. Recent value measures and cost-utilities. Evid Based Ophthalmol 2011; 12:203-209.
2. Brown MM, Brown GC, Brown HC, et al. The comparative effectiveness and cost-effectiveness of vitreoretinal interventions. Curr Opin Ophthalmol 2007; 19:200-207.
3. Brown MM, Brown GC, Sharma S. Evidence-based to value-based medicine. Chicago: AMA Press; 2005; pp. 1-265.
4. Brown GC, Brown MM, Menezes A, et al. Cataract surgery cost-utility revisited in 2012. A new economic paradigm. Ophthalmology 2013; 120: 2367-2376.
5. Actuaries at the Centers for Medicare and Medicaid Services. National Health Expenditure Projections 2012-2022. http://www.cms.gov/Research-Statis tics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpend Data/Downloads/Proj 2012.pdf. Accessed 15 January 2014.
6. Beauchamp GR. Physicians and nurses are economic value producers. Evid Based Ophthalmol 2006; 7:57-58. (Pubitemid 44509992)
7. Nordhaus WD. The health of nations: the contribution of improved health to living standards. NBER Working paper 8818. National Bureau of Economic Research. 2002. http://www.nber.org/papers/w8818. Accessed 10 January 2014.
8. U.S. Census Bureau. No. HS-16. Expectation of Life at Birth by Race and Sex: 1900 to 2001. http://www.census.gov/statab/hist/HS-16.pdf. Accessed 11 January 2014.
9. Brown GC, Brown MM, Lieske HB, et al. Comparative effectiveness and costeffectiveness analyses on the Implantable Miniature Telescope. Ophthalmology 2011; 118:1834-1843.
10. Brown MM, Brown GC, Brown HC, et al. Comparative effectiveness and cost-effectiveness analyses of VEGF-A inhibitor and 90Sr brachytherapy for neovascular macular degeneration. Evid Based Ophthalmol 2009; 10:107-122.
11. Brown MM, Brown GC. Update on value-based medicine. Curr Opin Ophthalmol 2013; 24:183-189.
12. Javitt JC, Zhou Z, Willke RJ. Association between vision loss and higher medical care costs in Medicare beneficiaries' costs are greater for those with progressive vision loss. Ophthalmology 2007; 114:238-245.
13. Bureau of Labor Statistics. Measuring price change for medical care in the CPI. http://www.bls.gov/cpi/cpifact4.htm. Accessed 10 January 2014.
14. Schmier JK, Halpern MT, Covert D, et al. Impact of visual impairment on use of caregiving by individuals with age-related macular degeneration. Retina 2006; 26:1056-1062. (Pubitemid 44973226)
15. Brault, Matthew W., 'Americans With Disabilities: 2010,' Current Population Reports, P70-131, U.S. Census Bureau, Washington, DC, 2012. http://www.census.gov/prod/201 2pubs/p70-131.pdf. Accessed 10 January 10 2014.
16. Brown GC. The comparative effectiveness of vitreoretinal interventions. Presented at Macula 2014; 11 January 2014; Wills Eye Hospital, Philadelphia.
17. Buffett W. Berkshire Hathaway 2012 letter to shareholders. March 1, 2013. http://berkshirehathaway.com/letters/2012ltr.pdf. Accessed 14 January 2014.
18. Henny C, Hartington K, Scott S, et al. The business case for telemedicine. Int Marit Health 2013; 64:129-135.
19. Bhaumik U, Norris K, Charron G, et al. A cost analysis for a community-based case management intervention program for pediatric asthma. J Asthma 2013; 50:310-317.
20. Spetz J, Brown DS, Aydin C, Donaldson N. The value of reducing hospitalacquired pressure ulcer prevalence: an illustrative analysis. J Nurs Adm 2013; 43:235-241.